Serum separation gel market seen reaching $13.97 billion by 2030

The serum separation gel market is projected to rise from $10.49 billion in 2026 to $13.97 billion by 2030, driven by growing diagnostic testing demand and chronic disease prevalence. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Serum separation gel is a core input for blood collection tubes used in clinical diagnostics, research and biotech workflows. - Faster serum isolation supports more accurate testing, quicker turnaround times and better sample stability in labs and hospitals. - The market’s growth reflects broader demand for diagnostic capacity as healthcare systems expand testing and screening.

What happened: - The Business Research Company released a serum separation gel market report dated 2026. - The report values the market at $10.49 billion in 2026, up from $9.66 billion in 2025. - The report projects the market will reach $13.97 billion by 2030. - The forecast implies a 7.4% compound annual growth rate from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

The details: - Serum separation gel is a gel-like material placed inside blood collection tubes. - The gel forms a barrier between serum and blood cells during centrifugation. - The separation process supports clinical and research analysis of serum samples. - The 2026 market expansion was tied to rising use of blood collection tubes for routine diagnostics. - Demand also rose for reliable serum separation in biochemical and immunological tests. - Early use of serum separation gels in both glass and plastic tubes supported adoption. - Hospital and clinic laboratory buildout added to demand. - Use of serum-based testing in research and biotechnology also contributed to growth. - The report says demand for high-performance gel formulations suited to automated processing is increasing. - The report also points to greater use of pre-filled gel packs and bulk gels for customized tube manufacturing. - Serum separation solutions are gaining acceptance in pharmaceutical and biotech research. - Expanded use in large-scale screening and blood banking is expected to support further growth. - Industry demand is also being shaped by emphasis on sample stability, accuracy and turnaround times. - Gel-based tubes are becoming more common for precise serum isolation. - Powder and liquid gel forms are both used, depending on processing needs. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - Diagnostic testing remains the clearest demand engine because it ties gel usage to routine clinical workflows rather than discretionary spending. - Chronic disease prevalence adds a structural tailwind because more long-term disease monitoring increases the number of blood tests ordered. - The regional split suggests mature demand in North America and more room for expansion in Asia-Pacific as lab infrastructure grows. - The report’s focus on automated processing and customized tube manufacturing points to a market moving toward higher-throughput and more specialized products.

What's next: - The market is expected to keep expanding through 2030 as automated labs, screening programs and blood banking needs increase. - Growth will likely depend on continued adoption of gel formulations that improve processing speed, separation quality and sample handling. - The full report and sample are available from The Business Research Company via the sample report and the full market report.

The bottom line: - Serum separation gel demand is rising on the back of more diagnostic testing, more chronic disease monitoring and broader lab automation, with the market on track to add more than $3 billion by 2030.